#894: Ozempic 2.0? Fat Loss, Insulin, and the Future episode artwork

EPISODE · Sep 22, 2025 · 34 MIN

#894: Ozempic 2.0? Fat Loss, Insulin, and the Future

from The Health Revival Show | Hormone Therapy & Gut Health Insights

In this episode of The Health Revival Show, Liz & Becca break down Retatrutide—a new GLP-1, GIP, and glucagon receptor agonist that’s making waves in the functional health and metabolic space. Is it really “Ozempic on steroids”? They cut through the hype and bring the context no one’s talking about—the importance of muscle preservation, insulin sensitivity, thyroid health, and how to use these tools responsibly (or if at all). Whether you’re considering peptides or just curious about this next-gen weight loss compound, this episode delivers the no-BS truth.

Episode metadata supplied by the publisher feed · Published Sep 22, 2025

Embed this episode

NOW PLAYING

#894: Ozempic 2.0? Fat Loss, Insulin, and the Future

0:00 34:55

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Health Revival Show | Hormone Therapy & Gut Health Insights?

This episode is 34 minutes long.

When was this The Health Revival Show | Hormone Therapy & Gut Health Insights episode published?

This episode was published on September 22, 2025.

Can I download this The Health Revival Show | Hormone Therapy & Gut Health Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!